In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector

Human Gene Therapy

Volumn 21, Issue 1, 2010, Pages 40-50

  Kubo, Shuji ^a,b   Kataoka, Miho ^c   Tateno, Chise ^c   Yoshizato, Katsutoshi ^c,d   Kawasaki, Yoshiko ^b   Kimura, Takahiro ^a   Faure Kumar, Emmanuelle ^a   Palmer, Donna J ^e   Ng, Philip ^e   Okamura, Haruki ^b   Kasahara, Noriyuki ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c Hiroshima Prefectural Institute of Industrial Science and Technology   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HIGH CAPACITY ADENOVIRUS LENTIVIRUS HYBRID VECTOR; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; ENGRAFTMENT; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIVER; LIVER CELL; MOUSE; NONHUMAN; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CELL LINE; CELL MOVEMENT; CHIMERA; GENE EXPRESSION; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAVENOUS; LENTIVIRUS; LIVER; MICE; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; LENTIVIRUS; MURINAE; MUS;

EID: 74949129843     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.027     Document Type: Article

References (51)

1. Benihoud, K., Yeh, P., and Perricaudet, M. (1999). Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10, 440-447.
2. Bieniasz, P.D., and Cullen, B.R. (2000). Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74, 9868-9877.
3. Bosch, A., McCray, P.B., Jr., Chang, S.M., Ulich, T.R., Simonet, W.S., Jolly, D.J., and Davidson, B.L. (1996). Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J. Clin. Invest. 98, 2683-2687.
4. Caplen, N.J., Higginbotham, J.N., Scheel, J.R., Vahanian, N., Yoshida, Y., Hamada, H., Blaese, R.M., and Ramsey, W.J. (1999). Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther. 6, 454-459.
5. Chen, M., Kasahara, N., Keene, D.R., Chan, L., Hoeffler, W.K., Finlay, D., Barcova, M., Cannon, P.M., Mazurek, C., and Woodley, D.T. (2002). Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat. Genet. 32, 670-675.
6. Dandri, M., Burda, M.R., Torok, E., Pollok, J.M., Iwanska, A., Sommer, G., Rogiers, X., Rogler, C.E., Gupta, S., Will, H., Greten, H., and Petersen, J. (2001). Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33, 981-988. (Pubitemid 32246649)
7. De Vree, J.M., Ottenhoff, R., Bosma, P.J., Smith, A.J., Aten, J., and Oude Elferink, R.P. (2000). Correction of liver disease by he-patocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119, 1720-1730.
8. Dorigo, O., Gil, J.S., Gallaher, S.D., Tan, B.T., Castro, M.G., Lowenstein, P.R., Calos, M.P., and Berk, A.J. (2004). Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. J. Virol. 78, 6556-6566.
9. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., and Calos, M.P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
10. Emoto, C., Tateno, C., Hino, H., Amano, H., Imaoka, Y., Asa-hina, K., Asahara, T., and Yoshizato, K. (2005). Efficient in vivo xenogeneic retroviral vector-mediated gene transduction into human hepatocytes. Hum. Gene Ther. 16, 1168-1174.
11. Feng, M., Jackson, W.H., Jr., Goldman, C.K., Rancourt, C., Wang, M., Dusing, S.K., Siegal, G., and Curiel, D.T. (1997). Stable in vivo gene transduction via a novel adenoviral=retroviral chimeric vector [see comments]. Nat. Biotechnol. 15, 866-870.
12. Ferry, N., and Heard, J.M. (1998). Liver-directed gene transfer vectors. Hum. Gene Ther. 9, 1975-1981.
13. Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
14. Harui, A., Suzuki, S., Kochanek, S., and Mitani, K. (1999). Frequency and stability of chromosomal integration of adenovi-rus vectors. J. Virol. 73, 6141-6146.
15. Hofmann, W., Schubert, D., Labonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., and Sodroski, J. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028.
16. Huard, J., Lochmuller, H., Acsadi, G., Jani, A., Massie, B., and Karpati, G. (1995). The route of administration is a major determinant of the transduction efficiency of rat tissues by ade-noviral recombinants. Gene Ther. 2, 107-115.
17. Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D.H., Alvira, M., Buttrick, P.M., and Leinwand, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
18. Katoh, M., Matsui, T., Nakajima, M., Tateno, C., Kataoka, M., Soeno, Y., Horie, T., Iwasaki, K., Yoshizato, K., and Yokoi, T. (2004). Expression of human cytochromes P450 in chimeric mice with humanized liver. Drug Metab. Dispos. 32, 1402-1410.
19. Kim, I.H., Jozkowicz, A., Piedra, P.A., Oka, K., and Chan, L. (2001). Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. U.S.A. 98, 13282-13287.
20. Kochanek, S. (1999). High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther. 10, 2451-2459.
21. Korin, Y.D., and Zack, J.A. (1998). Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168.
22. Kubo, S., Kiwaki, K., Awata, H., Katoh, H., Kanegae, Y., Saito, I., Yamamoto, T., Miyazaki, J., Matsuda, I., and Endo, F. (1997). In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice. Hum. Gene Ther. 8, 65-71.
23. Kubo, S., and Mitani, K. (2003). A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J. Virol. 77, 2964-2971.
24. Leblois, H., Roche, C., Di Falco, N., Orsini, C., Yeh, P., and Perricaudet, M. (2000). Stable transduction of actively dividing cells via a novel adenoviral=episomal vector. Mol. Ther. 1, 314-322.
25. Li, Q., Kay, M.A., Finegold, M., Stratford-Perricaudet, L.D., and Woo, S.L. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
26. Lieber, A., He, C.Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B., and Kay, M.A. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71, 8798-8807.
27. Lieber, A., Steinwaerder, D.S., Carlson, C.A., and Kay, M.A. (1999). Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. 73, 9314-9324. (Pubitemid 29487087)
28. Mariani, R., Rutter, G., Harris, M.E., Hope, T.J., Krausslich, H.G., and Landau, N.R. (2000). A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74, 3859-3870.
29. Mercer, D.F., Schiller, D.E., Elliott, J.F., Douglas, D.N., Hao, C., Rinfret, A., Addison, W.R., Fischer, K.P., Churchill, T.A., Lakey, J.R., Tyrrell, D.L., and Kneteman, N.M. (2001). Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7, 927-933.
30. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
31. Nguyen, T.H., Oberholzer, J., Birraux, J., Majno, P., Morel, P., and Trono, D. (2002). Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary he-patocytes. Mol. Ther. 6, 199-209.
32. Oka, K., Pastore, L., Kim, I.H., Merched, A., Nomura, S., Lee, H.J., Merched-Sauvage, M., Arden-Riley, C., Lee, B., Finegold, M., Beaudet, A., and Chan, L. (2001). Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 103, 1274-1281.
33. Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus=vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406.
34. Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.N., Finegold, M., and Grompe, M. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 12, 266-273.
35. Palmer, D., and Ng, P. (2003). Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8, 846-852.
36. Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M.A. (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24, 49-52.
37. Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, M.A., and Graham, F.L. (1996). A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U.S.A. 93, 13565-13570.
38. Patijn, G.A., Lieber, A., Schowalter, D.B., Schwall, R., and Kay, M.A. (1998). Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 28, 707-716.
39. Picard-Maureau, M., Kreppel, F., Lindemann, D., Juretzek, T., Herchenroder, O., Rethwilm, A., Kochanek, S., and Heinke-lein, M. (2004). Foamy virus\-adenovirus hybrid vectors. Gene Ther. 11, 722-728.
40. Recchia, A., Parks, R.J., Lamartina, S., Toniatti, C., Pieroni, L., Palombo, F., Ciliberto, G., Graham, F.L., Cortese, R., La Monica, N., and Colloca, S. (1999). Site-specific integration mediated by a hybrid adenovirus=adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 96, 2615-2620. (Pubitemid 29148766)
41. Robbins, P.B., Skelton, D.C., Yu, X.J., Halene, S., Leonard, E.H., and Kohn, D.B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 10182-10187.
42. Schiedner, G., Morral, N., Parks, R.J., Wu, Y., Koopmans, S.C., Langston, C., Graham, F.L., Beaudet, A.L., and Kochanek, S. (1998). Genomic DNA transfer with a high-capacity adenovi-rus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18, 180-183.
43. Sena-Esteves, M., Saeki, Y., Fraefel, C., and Breakefield, X.O. (2000). HSV-1 amplicon vectors\-simplicity and versatility. Mol. Ther. 2, 9-15.
44. Serafini, M., Naldini, L., and Introna, M. (2004). Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivec-tors. Virology 325, 413-424.
45. Soifer, H., Higo, C., Kazazian, H.H., Jr., Moran, J.V., Mitani, K., and Kasahara, N. (2001). Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector. Hum. Gene Ther. 12, 1417-1428.
46. Soifer, H., Higo, C., Logg, C.R., Jih, L.J., Shichinohe, T., Harboe-Schmidt, E., Mitani, K., and Kasahara, N. (2002). A novel, helper-dependent, adenovirus-retrovirus hybrid vector: Stable transduction by a two-stage mechanism. Mol. Ther. 5, 599-608.
47. Tan, B.T., Wu, L., and Berk, A.J. (1999). An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency. J. Virol. 73, 7582-7589.
48. Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., Asahara, T., Yokoi, T., Furukawa, T., and Yoshizato, K. (2004). Near completely humanized liverinmice shows human-type metabolic responses to drugs. Am. J. Pathol. 165, 901-912.
49. Umana, P., Gerdes, C.A., Stone, D., Davis, J.R., Ward, D., Castro, M.G., and Lowenstein, P.R. (2001). Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat. Bio-technol. 19, 582-585.
50. Wivel, N.A., Gao, G.-P., and Wilson, J.M. (1999). Adenovirus vectors. In The Development of Human Gene Therapy. T. Fried-mann, ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 87-110.
51. Yant, S.R., Ehrhardt, A., Mikkelsen, J.G., Meuse, L., Pham, T., and Kay, M.A. (2002). Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat. Biotechnol. 20, 999-1005.